-
FDA accepts application for license for complementary biologics for new anti-inflammatory drug Dupixent
Time of Update: 2020-06-10
, France's Pharmaceutical (http:// giant Sanofi and its partner, Regeneron, announced that the of food and drugs (http:// Administration ( FDA (http:// ) had accepted an application for a lice
-
FDA grants FibroGen monoclonal antibody pamrevlumab for orphan drug treatment of Duchenne muscular dystrophy
Time of Update: 2020-06-10
recently, FibroGen 's (http:// announced that the Administration of the food and drugs (http:// Administration ( FDA (http:// ) has granted the experimental anti-CTGF monoclonal antibody rect
-
NICE approves anti-inflammatory drug Tildrakizumab for treatment of adult patients with moderate to severe plaque psoriasis
Time of Update: 2020-06-10
recently, (http:// a company at Pharmaceuticals (http:// ) in Spain, announced that the National Institute for Health and Clinical Optimization (NICE) had approved the anti-inflammatory drug Ilu
-
CHMP recommends approval of Pfizer Zirabev for treatment of multiple cancers
Time of Update: 2020-06-10
, Pfizer, the giant of the Pharmaceutical (http:// announced that the European Pharmaceutical (http:// Administration (http:// Product son-in- (http:// Committee (CHMP) had issued a positiv
-
FDA approves Taiho Oncology's Lonsurf for treatment of adult patients with stomach cancer
Time of Update: 2020-06-10
recently http:// , Taiho Oncology, a u.S sub-http:// company taiho, announced that the U.S Food and Drug (http:// Administration ( FDA (http:// , had approved Lon (trisurffrancie/tipiracil,
-
Drug registration application for treatment of NSCLC patients by Beida Pharmaceuticals Ensatinib has been approved by the National Drug Administration
Time of Update: 2020-06-10
recently, The National Medicines (http:// Regulatory Authority has accepted the registration of drugs for patients with their statine nsatinib for patients with pre-conditioned metastatic lymphom
-
Almiral launches Seysara tablets in the U.S. for treatment of common acne patients
Time of Update: 2020-06-10
recently, Spain's Almiral company (http:// announced the launch of Seysara tablets in the United States for treatment of patients with moderate to severe non-nodactive inflammatory acne at age 9
-
Study finds combination drug therapy can reduce the risk of triple-negative breast cancer spreading to other parts of the body
Time of Update: 2020-06-10
researchers at the University of Missouri have now found that the combination of drug (http:// treatment can reduce the risk of spreading triple-negative breast cancer to other parts of the body
-
FDA approves launch of AbbVie IL-23-specific inhibitor Skyrizi (risankizumab)
Time of Update: 2020-06-10
today, AbbVie (http:// announced that it FDA (http:// approved its development of the IL-23-specific inhibitor Skyrizi (risankizumab) for the treatment of patients with severe psoriasis In cl
-
Clinical registration application for tAEST16001 new drug submitted by Xiang Xue Pharmaceuticals to the State Drug Administration has been approved
Time of Update: 2020-06-10
recently, Guangzhou Xiangxue Pharmaceutical (http:// limited shares of the company (http:// ("Shan Xue Pharmaceuticals") announced that its subsidiary, Guangdong Xiangxue Precision Medical (h
-
FDA approves Mersadon Keytruda and Inlyta combination therapy to treat patients with advanced renal cell cancer
Time of Update: 2020-06-10
recently, The FDA (http:// approved a combination of Heavy Anti-PD-1 therapy Keytruda and Inlyta (axitinib) for first-line treatment for patients with advanced renal cell carcinoma (RCC) the sec
-
Esperion publishes results of Phase 3 clinical trial on long-term safety of the new drug bempedoic acid
Time of Update: 2020-06-10
recently, Esperion (http:// announced that it is developing the results of the long-term trial (http:// for long-term safety the new drug (http:// ) bempedoic acid About Bempedoic acid Bem
-
FDA approves Gelesis company Plenity listing to help adults control weight
Time of Update: 2020-06-10
typically have a BMI of more than 25 that is considered overweight, while a BMI of more than 30 is considered obese , gelesis (http:// announced that the U.S FDA (http:// approveits its produ
-
Hainan sea medicine injection with cephalosporine sodium approved by the State Drug Administration
Time of Update: 2020-06-10
recently, Hainan Hai Pharmaceuticals announced that its son company (http:// Haikou Pharmaceutical Factory (http:// Co., Ltd received the State Drug (http:// Supervision Authority approved
-
Cinda Bio's Cindy Dilly Single Anti-Injection (Dabershu) has been officially approved for listing by the State Drug Administration
Time of Update: 2020-06-10
recently, Cinda Bio's PD-1 monoclonal antibody Sindili monoantigen (commodity name: Dabershu) was officially approved by the National Medicines (http:// Regulatory Authority to treat at least sec
-
Study finds that palbociclib and MLN0128 are co-anti-cancer active for TNBC
Time of Update: 2020-06-10
triple-negative breast cancer (TNBC) accounts for about 13-22% of breast cancer, so far, no targeted treatment for TNBC has been approved recently, published in Breast Cancer Research and Treatment
-
Yan Jian's Nosin asodium injection (SPINRAZA) has been officially approved by the State Drug Administration
Time of Update: 2020-06-10
yesterday (February 28), the of the Company (http:// announced that the Nosina sodium injection (THE U.S and EU-registered trade name SPINRAZA) has been officially approved by the National Drug
-
Amin launches new osteoporosis drug Evenity in U.S. market
Time of Update: 2020-06-10
recently, Amgen announced the launch of the new (http:// of osteoporo sis in the US market Evenity was approved a week ago by the u.S FDA (http:// for treatment of osteoporosis in postmenopaus
-
FDA approves abid for Aerie's second new drug, Rocklatan, to go public
Time of Update: 2020-06-10
recently, Aerie Pharmaceuticals (http:// announced that it had approved the listing of its second new drug (http:// rocklatan the of the Http:// About Rocklatan Daily Eye Drop Sfluid Rock
-
FDA accelerates approval of new indications for targeted cancer drug Venetoxta
Time of Update: 2020-06-10
, AbbVie and partner Roche announced that the Authority of the of food and drugs (http:// ( FDA (http:// ) has accelerated the approval of a new indication of the anti-cancer drug Venetoxta, a l
